News:

This week IPhone 15 Pro winner is karn
You can be too a winner! Become the top poster of the week and win valuable prizes.  More details are You are not allowed to view links. Register or Login 

Main Menu

Appeals court upholds patent on Merck's Vytorin

Started by riky, February 08, 2013, 09:00:18 AM

Previous topic - Next topic

0 Members and 1 Guest are viewing this topic.

riky

Appeals court upholds patent on Merck's Vytorin

<p><a href="http://news.yahoo.com/appeals-court-upholds-patent-mercks-vytorin-172819967--finance.html"><img src="http://l1.yimg.com/bt/api/res/1.2/V2i7wfS1xlkoBfKht6kU9A--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9ODU7dz0xMzA-/http://media.zenfs.com/en_us/News/Reuters/2013-02-07T193233Z_1_CBRE9161IAB00_RTROPTP_2_SCHERINGPLOUGH-MERCK.JPG" width="130" height="86" alt="Handout of Merck cholesterol drug Vytorin" align="left" title="Handout of Merck cholesterol drug Vytorin" border="0" /></a>WASHINGTON (Reuters) - The patent on Merck &amp; Co's cholesterol fighters Zetia and Vytorin, two of the drugmaker's biggest products, is valid, a U.S. appeals court ruled on Thursday. Vytorin combines Zocor, a member of the statin family developed by Merck, with a newer Merck cholesterol treatment called Zetia. Sales of Vytorin are $1.75 billion while sales of Zetia used by itself are another $2.6 billion a year. The U.S. Court of Appeals for the Federal Circuit did not discuss the ruling at length and simply affirmed a decision by a lower court in New Jersey. The U.S. ...</p><br clear="all"/>

Source: You are not allowed to view links. Register or Login
You are not allowed to view links. Register or Login